Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works
Sep 25, 2023, 10:25 PM
Share
Subscribe
AP correspondent Jackie Quinn reports on MED ALS Treatment FDA.
We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.
Please check your internet connection and refresh the page. You might also try disabling any ad blockers.
You can visit our support center if you're having problems.